It is the general consensus of scientists that cancer vaccines will become a reality. Overall the cancer treatment market continues to grow and this demand sets the stage for vaccine products. Several promising vaccines: the propholactic Gardasil has created a pathway for new vaccine products. M-Vax, Ocon-Vax in late stage development and are preparing for regulatory review in the United States, Europe, Canada, or other international regions. Many of the products with potential approval status over the coming years are already in Phase III development, have orphan drug status, SPA status, or Fast Track status. This provides a promising future for many of these products. Additionally, some products in international regions have been granted compassionate use status which is significant in evaluating need on a patient-by-patient basis. In this report, Kalorama Information provides a realistic estimate of the cancer vaccine for the near term for the following products:
Related Reports: Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing IndustryJun 1, 2009 - KLI2155319 - $3,995.00 The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition May 1, 2009 - KLI2218043 - $3,995.00 Retail Clinics and the In-Store Healthcare Market 2009: Bright Spot in the Current Economy? Mar 1, 2009 - KLI2041111 - $3,500.00 Women's Health: Worldwide Prescription Drug Markets Feb 1, 2009 - KLI2071673 - $2,995.00 Protein Therapeutics: Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments, Global Market Dec 1, 2008 - KLI1646601 - $3,495.00 Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Apr 1, 2008 - KLI1682234 - $4,100.00 The Worldwide Market for Cancer Diagnostics, 3rd Edition Mar 1, 2008 - KLI1393082 - $3,995.00 Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market May 1, 2007 - KLI1469934 - $995.00 Cancer Therapeutics: The Worldwide Market , 2nd Edition Feb 1, 2007 - KLI1365882 - $2,500.00 Vaccines: The World Market Feb 1, 2007 - KLI1351010 - $3,995.00 |
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
Clinical Nutrition Products: World Market, 2nd. Edition
Clinical Nutrition Products: World Markets, 3rd Edition
Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
Prescription Dermatological Drugs: Worldwide Market, 6th Edition
|
|||||||||
|
Privacy Policy
|
Terms and Conditions
|
Site Map
|
Return Policy
|
Press
|
Help FAQs
|